FOLFOX + Bevacizumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FOLFOX + Bevacizumab, covering 2013-11-04 to 2019-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells [Phase 3]